Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials.
Michael SticherlingArjen F NikkelsAshraf M HamzaPearl KwongJacek C SzepietowskiMahira El SayedPierre-Dominique GhislainAlkes A KhotkoManmath PatekarChristine-Elke OrtmannPascal ForrerPhilemon PapanastasiouDeborah KeefePublished in: American journal of clinical dermatology (2023)
NCT03668613 (Novartis Study Code CAIN457A2311, referred to as A2311), actual study start date: August 29, 2018; actual primary completion date: September 19, 2019; estimated study completion date: September 14, 2023. NCT02471144 (Novartis Study Code CAIN457A2310, referred to as A2310), study start date: September 29, 2015; primary completion date: December 13, 2018; estimated study completion date: March 31, 2023.